We provide actionable insights for patients with systemic autoimmune disease.

smiling female doctor

Current Scleroderma patient experience

  • Scleroderma or systemic sclerosis (SSc) is a progressive multisystem disease of unknown etiology, marked by cutaneous fibrosis, internal organ fibrosis as well as abnormalities of the immune system and vasculature
  • It remains a rare disease with ~27.6 cases per 100,000 in the US
  • While five-year survival has increased from 69% to 84% in the past couple of decades, there is substantial quality-of-life burden, as well as significant mortality and morbidity associated with scleroderma
  • Current treatments do not significantly alter the course of disease and are directed at symptoms/dysfunctional organs
  • Current diagnosis focuses on skin characteristics and does not predict disease progression

Current Systemic Lupus Erythematosus patient experience

  • Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that damages tissue in many parts of the body, including skin, joints, lungs, and kidneys
  • SLE is a leading cause of death for women with 20-150 cases per 100,000 people
  • The average delay of 6 years between disease onset and proper medical attention/diagnosis is a significant unmet need
  • Optimal time to treat patients is in the early and active stages of disease, before irreversible damage to tissues
  • Lack of prognostic biomarkers makes the development of disease-modifying therapies and preventative care extremely difficult
  • 10-15% of Lupus patients will experience premature death due to disease-related complications
women hiking with kids
doctor with patient

ImmuType has potential application in all systemic autoimmune diseases

Get in touch

If you are interested in ImmuType services and would like additional information.

Engage ImmuType